Psoriasis research has progressed impressively over the past years. New insights into its
pathogenesis and the study of novel therapies have made psoriasis a model disorder and
have revealed basic cellular and molecular mechanisms underlying chronic inflammatory
disorders. In this issue, renowned experts provide a comprehensive view on many aspects
of psoriasis including clinical spectrum, pathogenesis, epidemiology, phychosocial and
economical considerations, and therapeutic implications. Few skin disorders highlight the …